Pay in 4 interest-free payments of $5.94 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Given the first-mover commercial advantages documented in biosimilar markets (the first two to three entrants have consistently captured over 90% of biosimilar market share in physician-administered settings), the race-to-market analysis is as commercially important as the patent litigation analysis
Liang Y, Osborne MC, Monia BP et al (2004) Reduction in glucagon receptor expression by an antisense oligonucleotide ameliorates diabetic syndrome in db/db mice
Not surprisingly, patients with naturally darker skin color more commonly develop PIH, and this observation appears to be independent of ethenicity
And they're not for everyone or for every wallet
.png)
US$ 28.76
US$ 20.98
US$ 28.09
US$ 29.88
